Bio-Techne (TECH) Total Current Liabilities (2010 - 2026)

Bio-Techne's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $153.3 million for Q1 2026.

• In Q1 2026, Total Current Liabilities fell 9.41% year-over-year to $153.3 million; the TTM figure through Mar 2026 stood at $153.3 million (down 9.41% YoY), while the FY2025 annual figure was $175.8 million, up 10.33% from the prior year.
• Total Current Liabilities was $153.3 million for Q1 2026 at Bio-Techne, up from $140.4 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $176.0 million in Q2 2022 to a low of $127.8 million in Q3 2023.
• Historically, Total Current Liabilities has averaged $149.3 million across 5 years, with a median of $144.5 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Total Current Liabilities declined 26.99% in 2023, then gained 24.02% in 2024.
• A 5-year view of Total Current Liabilities shows it stood at $128.4 million in 2022, then gained by 5.32% to $135.2 million in 2023, then increased by 19.24% to $161.3 million in 2024, then retreated by 12.92% to $140.4 million in 2025, then advanced by 9.15% to $153.3 million in 2026.
• The last three Total Current Liabilities figures came in at $153.3 million (Q1 2026), $140.4 million (Q4 2025), and $144.5 million (Q3 2025), per Business Quant data.